August 8, 2000Estratab Tablets Recalled
GA (SafetyAlerts) - The Food and
Drug Administration (FDA) today reported that Solvay Pharmaceuticals, Inc. is conducting a
recall of Estratab because the tablets did not meet friability specification.
Estratab(r) (Esterified Estrogens Tablets, USP), 2.5 mg, in bottles of 100, Rx intended
for hormone replacement.
Recall #D-444-0. Class III
Lot #90654 exp 6/01.
Solvay Pharmaceuticals, Inc., Baudette, Minnesota.
Solvay Pharmaceuticals, Inc., Marietta, Georgia, by letter on June 26, 2000.
Firm-initiated recall ongoing. This is the first public notice issued by the FDA.
2,282 bottles were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers August 8,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.